Your address will show here +12 34 56 78
DIVERSIFIED ACROSS MULTIPLE AREAS OF THE
MARIJUANA INDUSTRY

MCIG MISSION

We are on a mission to improve the well-being of people and planet. We believe that the future of hemp is unlimited. Through innovative and responsible application of science, we strive to enhance the prosperity and health of our employees, customers, and communities. We are committed to pioneering the CBD Evolution as the leading producer of quality hemp CBD products.

OVERVIEW

MCIG operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state-of-the art production facilities.

PHARMACEUTICALS

MCIG’ Pharmaceutical Division is developing synthetically-formulated cannabidiol-based medicine, pursuing the approval of the U.S. Food and Drug Administration (FDA) for drugs with specific indications utilizing cannabidiol as the active pharmaceutical ingredient. CV Sciences has achieved promising preclinical results in the development of cannabinoid medicines for treatment of a range of medical conditions.

CONSUMER PRODUCTS

MCIG’ Consumer Products Division delivers botanical-based cannabidiol products that enhance quality of life. Currently distributed nationally in health food stores, health care provider’s offices and online, each consumer products brand is backed by a formal safety review, growing body of case reports, and physician’s recommendations.

OUR ASSETS

IN THE NEWS

mCig has been featured in over 1000 articles by various print and online media sources.

Press Releases

MCIG, INC ANNOUNCES CORPORATE NAME CHANGE TO BOTS, INC TO REFLECT BROADER TECHNOLOGY DEVELOPMENT  COMMITMENT

May 18, 2020

JACKSONVILLE, FL / May 18, 2020 / BOTS, Inc. -formerly mCig, Inc. (OTCQB:MCIG) a leading distributor of innovative products, technologies, and service...

Press Releases

MCIG CEO Issues Shareholder Letter for Post-Pandemic Strategy

May 11, 2020

JACKSONVILLE, FL, May 11, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE –mCig, Inc. (MCIG)  CEO Paul Rosenberg publishes an open status letter ...

Press Releases

mCig Inc. Signs Letter of Intent with multi-state licensed PCAB accredited compounding, retail, and specialty pharmacy network.

March 12, 2020

JACKSONVILLE, FL, March, 13, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – mCig, Inc. (MCIG), an innovative biotech company focused on development ...